Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Rauen

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Frontiers in Cell and Developmental Biology|November 22, 2021
iPSC-Derived Microglia as a Model to Study Inflammation in Idiopathic Parkinson's DiseaseKatja Badanjak, Patrycja Mulica, Semra Smajic, et al.
NPJ Parkinson'S Disease|December 18, 2023
Impaired neuron differentiation in GBA-associated Parkinson's disease is linked to cell cycle defects in organoidsIsabel Rosety, Alise Zagare, Claudia Saraiva, et al.
Journal of the American Society of Nephrology : JASN|October 4, 2018
Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR LossStephen Zewinger, Thomas Rauen, Michael Rudnicki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2013
YB-1 is an early and central mediator of bacterial and sterile inflammation in vivoLydia Hanssen, Christina Alidousty, Sonja Djudjaj, et al.
The New England Journal of Medicine|December 3, 2015
Intensive Supportive Care plus Immunosuppression in IgA NephropathyThomas Rauen, Frank Eitner, Christina Fitzner, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA NephropathyThomas Rauen, Christina Fitzner, Frank Eitner, et al.
Kidney International|May 26, 2020
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathyThomas Rauen, Stephanie Wied, Christina Fitzner, et al.
Clinical Immunology (Orlando, Fla.)|November 20, 2022
Could Osteopontin be a useful biomarker in the diagnosis and severity assessment of osteoarthritis? A systematic review and meta-analysis of recent evidenceRamy Abdelnaby, Yousef Tarek Sonbol, Khaled T Dardeer, et al.
Journal of Clinical Medicine|July 24, 2021
Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort StudyOliver Gross, Onnen Moerer, Thomas Rauen, et al.
Plos Genetics|February 11, 2017
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathwayKrzysztof Kiryluk, Yifu Li, Zina Moldoveanu, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Cell and Developmental Biology|November 22, 2021
iPSC-Derived Microglia as a Model to Study Inflammation in Idiopathic Parkinson's DiseaseKatja Badanjak, Patrycja Mulica, Semra Smajic, et al.
NPJ Parkinson'S Disease|December 18, 2023
Impaired neuron differentiation in GBA-associated Parkinson's disease is linked to cell cycle defects in organoidsIsabel Rosety, Alise Zagare, Claudia Saraiva, et al.
Journal of the American Society of Nephrology : JASN|October 4, 2018
Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR LossStephen Zewinger, Thomas Rauen, Michael Rudnicki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2013
YB-1 is an early and central mediator of bacterial and sterile inflammation in vivoLydia Hanssen, Christina Alidousty, Sonja Djudjaj, et al.
The New England Journal of Medicine|December 3, 2015
Intensive Supportive Care plus Immunosuppression in IgA NephropathyThomas Rauen, Frank Eitner, Christina Fitzner, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA NephropathyThomas Rauen, Christina Fitzner, Frank Eitner, et al.
Kidney International|May 26, 2020
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathyThomas Rauen, Stephanie Wied, Christina Fitzner, et al.
Clinical Immunology (Orlando, Fla.)|November 20, 2022
Could Osteopontin be a useful biomarker in the diagnosis and severity assessment of osteoarthritis? A systematic review and meta-analysis of recent evidenceRamy Abdelnaby, Yousef Tarek Sonbol, Khaled T Dardeer, et al.
Journal of Clinical Medicine|July 24, 2021
Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort StudyOliver Gross, Onnen Moerer, Thomas Rauen, et al.
Plos Genetics|February 11, 2017
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathwayKrzysztof Kiryluk, Yifu Li, Zina Moldoveanu, et al.
Pageof 9